Jublia 10% topical solution 8ML
Ended Awarded
- Contract number
- SPE2DB25FF71L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,673
Award facts
- Contract value 100% obligated
- $13,673.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,673.35 to AmerisourceBergen Drug Corp for the supply of Jublia 10% Topical Solution (8ml) on July 11, 2025, with an ultimate completion date of July 14, 2025. This firm fixed price delivery order represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical and medical supplies vendor for federal military and veteran healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its significant IDC with DLA, positions it as a primary supplier supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Jublia, a topical antifungal medication, exemplifies the routine pharmaceutical procurement activity managed through AmerisourceBergen's established federal contract infrastructure.
Quick answers
Who was awarded contract SPE2DB25FF71L?
SPE2DB25FF71L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 11, 2025.
How much is contract SPE2DB25FF71L worth?
The government has obligated $13,673 on SPE2DB25FF71L.
Is contract SPE2DB25FF71L an order under another contract?
Yes. SPE2DB25FF71L is a delivery order under SPE2DB20D1047, an indefinite delivery contract.
Was contract SPE2DB25FF71L competed?
The extent of competition for SPE2DB25FF71L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award